Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib (Q46934958)
scientific article published in February 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib |
scientific article published in February 2006 |
Statements
1 reference
Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib (English)
1 reference
1 reference
William Pao
1 reference
Marc Ladanyi
1 reference
Gregory J Riely
1 reference
Maureen F Zakowski
1 reference
Naiyer Rizvi
1 reference
Duykhanh Pham
1 reference
Allan R Li
1 reference
Ennapadam S Venkatraman
1 reference
Vincent A Miller
1 reference
1 February 2006
1 reference
12
1 reference
3 Pt 1
1 reference
839-844
1 reference